Trials / Unknown
UnknownNCT02035683
PET/CT Scan as a Tool to Rationalize the Treatment of of Advanced NSCLC Patients Undergoing First Chemotherapy
Study of the Role of Metabolic Response Measured by PET/CT Scan After 1 Cycle of Chemotherapy in Patients With Advanced Non Small Cell Lung Cancer (NSCLC)
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 220 (estimated)
- Sponsor
- National Cancer Institute, Naples · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to test whether an early metabolic response, measured by PET/CT scan after the first cycle of chemotherapy, is able to predict which patients with advanced NSCLC have a better prognosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | PET/CT | PET/CT scan at baseline and 3 weeks after first cycle chemotherapy |
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2024-12-01
- Completion
- 2024-12-01
- First posted
- 2014-01-14
- Last updated
- 2023-03-24
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT02035683. Inclusion in this directory is not an endorsement.